The trademark application vsy biotechnology acriva ud revo-tri pseudophakic supplementary iol was filed by VSY BIYOTEKNOLOJI VE ILAÇ SANAYI ANONIM SIRKETI, a corporation established under the laws of the Republic of Turkey (the "Applicant"). The application was published for oppositions on March 8, 2021, and it was registered by office on June 15, 2021 without any oppositions.
The application was filed in English (Spanish was selected as the second language).